Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03852485 · ClinicalTrials.gov registry record
Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 199
- Enrollment target
NCT03852485: Completed study, sponsored by Optovue.
NCT03852485 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 199 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03852485 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
Comparison of OCT and OCTA-based Ocular Measurements to those of Predicate
Primary Outcome
estimation of the interval within which a proportion of the differences between measurements lie
Interventions
- DEVICE SD-OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2019-08-30 |
What the finished NCT03852485 record still lists
NCT03852485 is an observational study that tracks outcomes without assigning an intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SD-OCT is the first listed.
NCT03852485 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03852485 about?
NCT03852485 is a clinical study titled "Comparison of OCT and OCTA-based Ocular Measurements to Those of Predicate". Comparison of OCT and OCTA-based Ocular Measurements to those of Predicate
What is the current status of trial NCT03852485?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2019-01-29. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT03852485?
The interventions under investigation include: SD-OCT (DEVICE).
Who is sponsoring clinical trial NCT03852485?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI